Clinical Trials Browser

Phase 3 × Withdrawn × Adenomatous Polyposis Coli × Clear all

NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Withdrawn

Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli